Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diseases of the Thyroid

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    July 2019
  1. BONGIOVANNI M, Faquin W, Giovanella L, Durante C, et al
    Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspicious for malignancy or malignant fine-needle aspiration cytology findings:
    Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0223.R1. doi: 10.1530/EJE-19-0223.
    PubMed     Text format     Abstract available


  2. SMITH TJ, Bartalena L
    Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy?
    Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0389.R1. doi: 10.1530/EJE-19-0389.
    PubMed     Text format     Abstract available


    June 2019
  3. WANG B, He W, Li Q, Jia X, et al
    U-shaped relationship between iodine status and thyroid autoimmunity risk in adults.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0212.R1. doi: 10.1530/EJE-19-0212.
    PubMed     Text format     Abstract available


  4. GIOVANELLA L, Duntas LH
    MANAGEMENT OF ENDOCRINE DISEASE: The Role of rhTSH in the Management of Differentiated Thyroid Cancer: Pros and Cons.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0149.R2. doi: 10.1530/EJE-19-0149.
    PubMed     Text format     Abstract available


    May 2019
  5. TWITO O, Grozinsky-Glasberg S, Levy S, Bachar G, et al
    Clinico-pathological and Dynamic Prognostic Factors in Sporadic and Familial Medullary Thyroid Carcinoma - An Israeli Multicenter Study.
    Eur J Endocrinol. 2019 May 1. pii: EJE-18-1008.R1. doi: 10.1530/EJE-18-1008.
    PubMed     Text format     Abstract available


  6. LEE WK, Lee J, Kim H, Lee SG, et al
    Peripheral location and infiltrative margin predict invasive features of papillary thyroid microcarcinoma.
    Eur J Endocrinol. 2019 May 1. pii: EJE-18-1025.R1. doi: 10.1530/EJE-18-1025.
    PubMed     Text format     Abstract available


  7. EFFRAIMIDIS G
    MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in Autoimmune Thyroid Disease. Are they useful?
    Eur J Endocrinol. 2019 May 1. pii: EJE-19-0234.R1. doi: 10.1530/EJE-19-0234.
    PubMed     Text format     Abstract available


    April 2019
  8. TSENG CH
    Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Eur J Endocrinol. 2019 Apr 1. pii: EJE-19-0133.R1. doi: 10.1530/EJE-19-0133.
    PubMed     Text format     Abstract available


  9. CENSI S, Barollo S, Grespan E, Watutantrige-Fernando S, et al
    PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY.
    Eur J Endocrinol. 2019 Apr 1. pii: EJE-19-0073.R2. doi: 10.1530/EJE-19-0073.
    PubMed     Text format     Abstract available


  10. LILLEVANG-JOHANSEN M, Abrahamsen B, Jorgensen H, Brix TH, et al
    Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk.
    Eur J Endocrinol. 2019 Apr 1. pii: EJE-19-0006.R1. doi: 10.1530/EJE-19-0006.
    PubMed     Text format     Abstract available


    March 2019
  11. ROTONDI M, Carbone A, Coperchini F, Fonte R, et al
    DIAGNOSIS OF ENDOCRINE DISEASE: IgG4-related thyroid autoimmune disease.
    Eur J Endocrinol. 2019 Mar 1. pii: EJE-18-1024.R1. doi: 10.1530/EJE-18-1024.
    PubMed     Text format     Abstract available


    January 2019
  12. VAN DER TUIN K, Ventayol M, Corver W, Khalifa M, et al
    Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma.
    Eur J Endocrinol. 2019 Jan 1. pii: EJE-18-0653.R1. doi: 10.1530/EJE-18-0653.
    PubMed     Text format     Abstract available


    December 2018
  13. ZHANG L, Castellana M, Virili C, Crescenzi A, et al
    Fine-needle aspiration to diagnose primary thyroid lymphoma: a systematic review and meta-analysis.
    Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0672.R1. doi: 10.1530/EJE-18-0672.
    PubMed     Text format     Abstract available


    November 2018
  14. DEANDREA M, Garino F, Mormile A, Garberoglio R, et al
    Radiofrequency ablation for benign thyroid nodules according to different US features: an Italian multicentre prospective study.
    Eur J Endocrinol. 2018 Nov 1. pii: EJE-18-0685.R1. doi: 10.1530/EJE-18-0685.
    PubMed     Text format     Abstract available


    October 2018
  15. BURCH HB, Cooper DS
    ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later
    Eur J Endocrinol. 2018;179:R261-R274.
    PubMed     Text format     Abstract available


  16. IGLESIAS FELIP C, Zafon C, Temprana-Salvador J, Garcia-Burillo A, et al
    ONE-STEP NUCLEIC ACID AMPLIFICATION FOR INTRAOPERATIVE ANALYSIS OF SENTINEL LYMPH NODE IN PAPILLARY THYROID CARCINOMA.
    Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0624.R1. doi: 10.1530/EJE-18-0624.
    PubMed     Text format     Abstract available


  17. SUH B, Shin DW, Park Y, Lim H, et al
    Increased Cardiovascular Risk in Thyroid Cancer Patients Taking Levothyroxine: a Nationwide Cohort Study in Korea.
    Eur J Endocrinol. 2018 Oct 1. pii: EJE-18-0551.R1. doi: 10.1530/EJE-18-0551.
    PubMed     Text format     Abstract available


    September 2018
  18. PETERS C, van Trotsenburg ASP, Schoenmakers N
    DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
    Eur J Endocrinol. 2018 Sep 24. pii: EJE-18-0383. doi: 10.1530/EJE-18-0383.
    PubMed     Text format     Abstract available


    July 2018
  19. CHAIGNEAU E, Russ G, Royer B, Bigorgne C, et al
    TIRADS score is of limited clinical value for risk stratification of indeterminate cytological results.
    Eur J Endocrinol. 2018;179:13-20.
    PubMed     Text format     Abstract available


    June 2018
  20. DEMARTINO L, McMahon R, Caggana M, Tavakoli NP, et al
    Gender disparities in screening for congenital hypothyroidism using thyroxine as a primary screen.
    Eur J Endocrinol. 2018 Jun 26. pii: EJE-18-0399. doi: 10.1530/EJE-18-0399.
    PubMed     Text format     Abstract available


  21. ALBANO D, Bertagna F, Bonacina M, Durmo R, et al
    Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
    Eur J Endocrinol. 2018 Jun 13. pii: EJE-18-0253. doi: 10.1530/EJE-18-0253.
    PubMed     Text format     Abstract available


  22. SONG E, Jeon MJ, Oh HS, Han M, et al
    Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classical papillary thyroid carcinoma?
    Eur J Endocrinol. 2018 Jun 6. pii: EJE-17-0991. doi: 10.1530/EJE-17-0991.
    PubMed     Text format     Abstract available


    May 2018
  23. HEINEN CA, Zhang Z, Klieverik LP, de Wit TC, et al
    Effects of Intravenous Thyrotropin Releasing Hormone on 18F-Fluorodeoxyglucose Uptake in Human Brown Adipose Tissue: A Randomized Controlled Trial.
    Eur J Endocrinol. 2018 May 3. pii: EJE-17-0966. doi: 10.1530/EJE-17-0966.
    PubMed     Text format     Abstract available


    April 2018
  24. WIERSINGA WM, Zarkovic M, Bartalena L, Donati S, et al
    PREDICTIVE SCORE FOR THE DEVELOPMENT OR PROGRESSION OF GRAVES' ORBITOPATHY IN PATIENTS WITH NEWLY DIAGNOSED GRAVES' HYPERTHYROIDISM.
    Eur J Endocrinol. 2018 Apr 12. pii: EJE-18-0039. doi: 10.1530/EJE-18-0039.
    PubMed     Text format     Abstract available


  25. SUN F, Zhang JX, Yang CY, Gao GQ, et al
    The Genetic Characteristics of Congenital Hypothyroidism in China by Comprehensive Screening of 21 Candidate Genes.
    Eur J Endocrinol. 2018 Apr 12. pii: EJE-17-1017. doi: 10.1530/EJE-17-1017.
    PubMed     Text format     Abstract available


  26. LAURIA A, Maddaloni E, Briganti SI, Beretta Anguissola G, et al
    Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules.
    Eur J Endocrinol. 2018 Apr 6. pii: EJE-18-0083. doi: 10.1530/EJE-18-0083.
    PubMed     Text format     Abstract available


    March 2018
  27. ROTONDI M, Capelli V, Coperchini F, Pinto S, et al
    Post partum and non-post partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs.
    Eur J Endocrinol. 2018 Mar 20. pii: EJE-17-1063. doi: 10.1530/EJE-17-1063.
    PubMed     Text format     Abstract available


  28. LEGER J, Forhan A, Dos Santos S, Larroque B, et al
    Developmental milestones at one year for the offspring of mothers with congenital hypothyroidism: a population-based study.
    Eur J Endocrinol. 2018 Mar 2. pii: EJE-17-0855. doi: 10.1530/EJE-17-0855.
    PubMed     Text format     Abstract available


    February 2018
  29. CARVALHO GA, Paz-Filho G, Mesa Junior CO, Graf H, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Pitfalls on the replacement therapy for primary and central hypothyroidism in adults.
    Eur J Endocrinol. 2018 Feb 28. pii: EJE-17-0947. doi: 10.1530/EJE-17-0947.
    PubMed     Text format     Abstract available


  30. SCOTT ES, Long GV, Guminski A, Clifton-Bligh RJ, et al
    The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma.
    Eur J Endocrinol. 2018;178:175-182.
    PubMed     Text format     Abstract available


  31. GIELDON L, Masjkur JR, Richter S, Darr R, et al
    Next-generation panel sequencing identifies NF1 germline mutations in three patients with pheochromocytoma but no clinical diagnosis of neurofibromatosis type 1.
    Eur J Endocrinol. 2018;178:K1-K9.
    PubMed     Text format     Abstract available


    January 2018
  32. GIOVANELLA L, Imperiali M, Verburg FA, Trimboli P, et al
    Early post-treatment risk stratification of differentiated thyroid cancer: comparison of three high-sensitive Tg assays.
    Eur J Endocrinol. 2018;178:77-84.
    PubMed     Text format     Abstract available


    December 2017
  33. NIES M, Dekker BL, Sulkers E, Huizinga GA, et al
    Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study.
    Eur J Endocrinol. 2017 Dec 18. pii: EJE-17-0741. doi: 10.1530/EJE-17-0741.
    PubMed     Text format     Abstract available


  34. WIERSINGA WM
    THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
    Eur J Endocrinol. 2017;177:R287-R296.
    PubMed     Text format     Abstract available


    November 2017
  35. APELLANIZ-RUIZ M, de Kock L, Sabbaghian N, Guaraldi F, et al
    Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame DICER1 deletion.
    Eur J Endocrinol. 2017 Nov 29. pii: EJE-17-0904. doi: 10.1530/EJE-17-0904.
    PubMed     Text format     Abstract available


  36. VELTRI F, Kleynen P, Grabczan L, Salajan A, et al
    Pregnancy outcomes are not altered by variation in thyroid function within the normal range in women free of thyroid disease.
    Eur J Endocrinol. 2017 Nov 29. pii: EJE-17-0628. doi: 10.1530/EJE-17-0628.
    PubMed     Text format     Abstract available


  37. FETENE DM, Betts KS, Alati R
    MECHANISMS IN ENDOCRINOLOGY: Maternal thyroid dysfunction during pregnancy and behavioural and psychiatric disorders of children: a systematic review.
    Eur J Endocrinol. 2017;177:R261-R273.
    PubMed     Text format     Abstract available


  38. ABE K, Narumi S, Suwanai AS, Adachi M, et al
    Association between monoallelic TSHR mutations and congenital hypothyroidism: a Statistical approach.
    Eur J Endocrinol. 2017 Nov 1. pii: EJE-16-1049. doi: 10.1530/EJE-16-1049.
    PubMed     Text format     Abstract available


    October 2017
  39. VELASCO II, Taylor PN
    DEBATE: IDENTIFYING AND TREATING SUBCLINICAL THYROID DYSFUNCTION IN PREGNANCY: EMERGING CONTROVERSIES.
    Eur J Endocrinol. 2017 Oct 25. pii: EJE-17-0598. doi: 10.1530/EJE-17-0598.
    PubMed     Text format     Abstract available


  40. VILLARROYA-MARQUINA I, Sancho J, Lorente-Poch L, Gallego-Otaegui L, et al
    TIME TO PARATHYROID FUNCTION RECOVERY IN PATIENTS WITH PROTRACTED HYPOPARATHYROIDISM AFTER TOTAL THYROIDECTOMY.
    Eur J Endocrinol. 2017 Oct 24. pii: EJE-17-0589. doi: 10.1530/EJE-17-0589.
    PubMed     Text format     Abstract available


  41. BASTOS AU, de Jesus AC, Cerutti JM
    ETV6-NTRK3 and STRN-ALK kinases fusions are recurrent events in papillary thyroid cancer of adult population.
    Eur J Endocrinol. 2017 Oct 18. pii: EJE-17-0499. doi: 10.1530/EJE-17-0499.
    PubMed     Text format     Abstract available


    September 2017
  42. SONG YS, Lim JA, Min HS, Kim MJ, et al
    Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer.
    Eur J Endocrinol. 2017 Sep 1. pii: EJE-17-0456. doi: 10.1530/EJE-17-0456.
    PubMed     Text format     Abstract available


    August 2017
  43. HAGLUND F, Hallstrom B, Nilsson IL, HOOg A, et al
    Inflammatory Infiltrates in Parathyroid Tumors.
    Eur J Endocrinol. 2017 Aug 30. pii: EJE-17-0277. doi: 10.1530/EJE-17-0277.
    PubMed     Text format     Abstract available


    July 2017
  44. KHAN SR, Bano A, Wakkee M, Korevaar T, et al
    The Association of Autoimmune Thyroid Disease (AITD) with Psoriatic Disease: a prospective cohort study, systematic review and meta-analysis.
    Eur J Endocrinol. 2017 Jul 26. pii: EJE-17-0397. doi: 10.1530/EJE-17-0397.
    PubMed     Text format     Abstract available


  45. BARJAKTAROVIC M, Korevaar T, Gaillard R, de Rijke YB, et al
    Childhood thyroid function, body composition and cardiovascular function.
    Eur J Endocrinol. 2017 Jul 19. pii: EJE-17-0369. doi: 10.1530/EJE-17-0369.
    PubMed     Text format     Abstract available


  46. LAIN S, Trumpff C, Grosse SD, Olivieri A, et al
    Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted? A debate.
    Eur J Endocrinol. 2017 Jul 10. pii: EJE-17-0107. doi: 10.1530/EJE-17-0107.
    PubMed     Text format     Abstract available


  47. CAPDEVILA J, Trigo JM, Aller J, Manzano JL, et al
    Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).
    Eur J Endocrinol. 2017 Jul 7. pii: EJE-17-0243. doi: 10.1530/EJE-17-0243.
    PubMed     Text format     Abstract available


  48. CHAN YX, Knuiman M, Divitini ML, Brown SJ, et al
    Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
    Eur J Endocrinol. 2017 Jul 6. pii: EJE-17-0197. doi: 10.1530/EJE-17-0197.
    PubMed     Text format     Abstract available


    June 2017
  49. BADZIONG J, Ting S, Synoracki S, Tiedje V, et al
    Differential Regulation of Monocarboxylate Transporter 8 Expression in Thyroid Cancer and Hyperthyroidism.
    Eur J Endocrinol. 2017 Jun 2. pii: EJE-17-0279. doi: 10.1530/EJE-17-0279.
    PubMed     Text format     Abstract available


  50. ALBUQUERQUE EV, Scalco RC, Jorge AA
    MANAGEMENT OF ENDOCRINE DISEASE: Diagnostic and therapeutic approach of tall stature.
    Eur J Endocrinol. 2017;176:R339-R353.
    PubMed     Text format     Abstract available


  51. DIAMANTI-KANDARAKIS E, Dattilo M, Macut D, Duntas L, et al
    MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.
    Eur J Endocrinol. 2017;176:R283-R308.
    PubMed     Text format     Abstract available


  52. SCHWENSEN CF, Brandt F, Hegedus L, Brix TH, et al
    Mortality in Graves' orbitopathy is increased and influenced by gender, age and pre-existing morbidity: a nationwide Danish register study.
    Eur J Endocrinol. 2017;176:669-676.
    PubMed     Text format     Abstract available


    May 2017
  53. RUGGERI RM, Trimarchi F, Biondi B
    MANAGEMENT OF ENDOCRINE DISEASE: L- THYROXINE REPLACEMENT THERAPY IN THE FRAIL ELDERLY: A CHALLENGE IN CLINICAL PRACTICE.
    Eur J Endocrinol. 2017 May 31. pii: EJE-17-0321. doi: 10.1530/EJE-17-0321.
    PubMed     Text format     Abstract available


  54. VUONG HG, Kondo T, Duong UNP, Pham TQ, et al
    PROGNOSTIC IMPACT OF VASCULAR INVASION IN DIFFERENTIATED THYROID CARCINOMA - A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Eur J Endocrinol. 2017 May 31. pii: EJE-17-0260. doi: 10.1530/EJE-17-0260.
    PubMed     Text format     Abstract available


  55. PANI F, Massidda M, Pusceddu V, Puzzoni M, et al
    REGORAFENIB-INDUCED HYPOTHYROIDISM AND CANCER RELATED-FATIGUE: IS THERE A POTENTIAL LINK?
    Eur J Endocrinol. 2017 May 3. pii: EJE-17-0231. doi: 10.1530/EJE-17-0231.
    PubMed     Text format     Abstract available


  56. BLIDDAL S, Boas M, Hilsted L, Friis-Hansen L, et al
    Increase in thyroglobulin antibody and thyroid peroxidase antibody levels, but not preterm birth-rate, in pregnant Danish women upon iodine fortification.
    Eur J Endocrinol. 2017;176:603-612.
    PubMed     Text format     Abstract available


    April 2017
  57. JEON MJ, Kim WG, Kwon H, Kim M, et al
    Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma.
    Eur J Endocrinol. 2017 Apr 21. pii: EJE-17-0160. doi: 10.1530/EJE-17-0160.
    PubMed     Text format     Abstract available


  58. BENJAMENS S, Dullaart RPF, Sluiter WJ, Rienstra M, et al
    The Clinical Value of Regular Thyroid Function Tests During Amiodarone Treatment.
    Eur J Endocrinol. 2017 Apr 19. pii: EJE-17-0018. doi: 10.1530/EJE-17-0018.
    PubMed     Text format     Abstract available


  59. LEGER J, Carel JC
    MANAGEMENT OF ENDOCRINE DISEASE: Arguments for the prolonged use of antithyroid drugs in children with Graves' disease.
    Eur J Endocrinol. 2017 Apr 5. pii: EJE-16-0938. doi: 10.1530/EJE-16-0938.
    PubMed     Text format     Abstract available


  60. ANDERSEN SL, Carle A, Karmisholt JS, Pedersen IB, et al
    MECHANISMS IN ENDOCRINOLOGY: Neurodevelopmental disorders in children born to mothers with thyroid dysfunction. Evidence of fetal programming?
    Eur J Endocrinol. 2017 Apr 4. pii: EJE-16-0947. doi: 10.1530/EJE-16-0947.
    PubMed     Text format     Abstract available


  61. KOREVAAR TI, Peeters RP
    The potential benefit of levothyroxine treatment during pregnancy: another step forward.
    Eur J Endocrinol. 2017;176:C3-C5.
    PubMed     Text format    


  62. VUONG HG, Kondo T, Pham TQ, Oishi N, et al
    Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis.
    Eur J Endocrinol. 2017;176:431-439.
    PubMed     Text format     Abstract available


  63. ROMERO-KUSABARA IL, Filho JV, Scalissi NM, Melo KC, et al
    Distinct inflammatory gene expression in extraocular muscle and fat from patients with Graves' orbitopathy.
    Eur J Endocrinol. 2017;176:481-488.
    PubMed     Text format     Abstract available


    March 2017
  64. CARLE A, Andersen SL, Boelaert K, Laurberg P, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Subclinical Thyrotoxicosis: Prevalence, Causes and Choice of Therapy.
    Eur J Endocrinol. 2017 Mar 8. pii: EJE-16-0276. doi: 10.1530/EJE-16-0276.
    PubMed     Text format     Abstract available


    February 2017
  65. LIU J, Sun W, Dong W, Wang Z, et al
    Risk factors for post-thyroidectomy hemorrhage: a meta- analysis.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0757. doi: 10.1530/EJE-16-0757.
    PubMed     Text format     Abstract available


  66. GIORDA CB, Carna P, Romeo F, Costa G, et al
    Prevalence, incidence, and associated co-morbidities of treated hypothyroidism. An update from a European population.
    Eur J Endocrinol. 2017 Feb 8. pii: EJE-16-0559. doi: 10.1530/EJE-16-0559.
    PubMed     Text format     Abstract available


  67. RUGGERI RM, Trimarchi F, Giuffrida G, Certo R, et al
    Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence.
    Eur J Endocrinol. 2017;176:133-141.
    PubMed     Text format     Abstract available


  68. STAN MN, Salvi M
    MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials.
    Eur J Endocrinol. 2017;176:R101-R109.
    PubMed     Text format     Abstract available


    January 2017
  69. TRIMBOLI P, Zilioli V, Imperiali M, Ceriani L, et al
    High-sensitive basal serum thyroglobulin 6-12 months after thyroid ablation is strongly associated with early response to therapy and event-free survival in patients with low to intermediate risk differentiated thyroid carcinomas.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-1011. doi: 10.1530/EJE-16-1011.
    PubMed     Text format     Abstract available


  70. KIM N, Gu JY, Yoo HJ, Han SE, et al
    Contact system activation and high thrombin generation in hyperthyroidism.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-0835. doi: 10.1530/EJE-16-0835.
    PubMed     Text format     Abstract available


  71. ZWAVELING-SOONAWALA N, Witteveen E, Marchal JP, Klouwer F, et al
    Early thyroxine treatment in Down syndrome and thyroid function later in life.
    Eur J Endocrinol. 2017 Jan 30. pii: EJE-16-0858. doi: 10.1530/EJE-16-0858.
    PubMed     Text format     Abstract available


  72. GROZINSKY-GLASBERG S, Bloom A, Lev-Cohain N, Klimov A, et al
    The Role of Hepatic Trans-Arterial Chemoembolization in Metastatic Medullary Thyroid Carcinoma: A Specialist Center Experience and Review of the Literature.
    Eur J Endocrinol. 2017 Jan 18. pii: EJE-16-0960. doi: 10.1530/EJE-16-0960.
    PubMed     Text format     Abstract available


  73. STRUJA T, Kaeslin M, Boesiger F, Jutzi R, et al
    External validation of the GREAT score to predict relapse risk in Graves' disease Results from a multicenter, retrospective study with 741 patients.
    Eur J Endocrinol. 2017 Jan 18. pii: EJE-16-0986. doi: 10.1530/EJE-16-0986.
    PubMed     Text format     Abstract available


  74. KWON H, Jeon MJ, Kim WG, Park S, et al
    A comparison of lobectomy and total thyroidectomy for patients with papillary thyroid microcarcinoma: a retrospective individual risk factor matched cohort study.
    Eur J Endocrinol. 2017 Jan 15. pii: EJE-16-0845. doi: 10.1530/EJE-16-0845.
    PubMed     Text format     Abstract available


  75. DOSIOU C, Medici M
    MANAGEMENT OF ENDOCRINE DISEASE: Isolated maternal hypothyroxinemia during pregnancy: knowns and unknowns.
    Eur J Endocrinol. 2017;176:R21-R38.
    PubMed     Text format     Abstract available


    December 2016
  76. PERGIALIOTIS V, Konstantopoulos P, Prodromidou A, Florou V, et al
    MANAGEMENT OF ENDOCRINE DISEASE: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis.
    Eur J Endocrinol. 2016 Dec 22. pii: EJE-16-0611. doi: 10.1530/EJE-16-0611.
    PubMed     Text format     Abstract available


  77. WELSH KJ, Soldin SJ
    DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
    Eur J Endocrinol. 2016;175:R255-R263.
    PubMed     Text format     Abstract available


  78. CHAKER L, Sedaghat S, Hoorn EJ, Elzen WP, et al
    The association of thyroid function and the risk of kidney function decline: a population-based cohort study.
    Eur J Endocrinol. 2016;175:653-660.
    PubMed     Text format     Abstract available


  79. WENDLER J, Kroiss M, Gast K, Kreissl MC, et al
    Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
    Eur J Endocrinol. 2016;175:521-529.
    PubMed     Text format     Abstract available


    November 2016
  80. NAZARPOUR S, Ramezani Tehrani F, Simbar M, Tohidi M, et al
    Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease.
    Eur J Endocrinol. 2016 Nov 22. pii: EJE-16-0548.
    PubMed     Text format     Abstract available


  81. RIESCO-EIZAGUIRRE G, Santisteban P
    ENDOCRINE TUMOURS: Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome.
    Eur J Endocrinol. 2016;175:R203-17.
    PubMed     Text format     Abstract available


    October 2016
  82. STRUJA T, Fehlberg H, Kutz A, Guebelin L, et al
    Can we predict relapse in Graves' disease? Results from a Systematic Review and Meta-analysis.
    Eur J Endocrinol. 2016 Oct 25. pii: EJE-16-0725.
    PubMed     Text format     Abstract available


  83. AKIROV A, Gimbel H, Grossman A, Shochat T, et al
    Elevated TSH in adults treated for hypothyroidism is associated with increased mortality.
    Eur J Endocrinol. 2016 Oct 19. pii: EJE-16-0708.
    PubMed     Text format     Abstract available


  84. BOAVENTURA P, Batista R, Pestana A, Reis M, et al
    TERT promoter mutations: A genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation.
    Eur J Endocrinol. 2016 Oct 19. pii: EJE-16-0740.
    PubMed     Text format     Abstract available


  85. DEKKERS OM, Erzsebet Horvath-Puho E, Cannegieter SC, Vandenbroucke J, et al
    Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: population-based cohort study.
    Eur J Endocrinol. 2016 Oct 3. pii: EJE-16-0576.
    PubMed     Text format     Abstract available


  86. BOGUSZEWSKI CL, Ayuk J
    MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and cancer: an old debate revisited.
    Eur J Endocrinol. 2016;175:R147-56.
    PubMed     Text format     Abstract available


    September 2016
  87. BRUSCA N, Virili C, Cellini M, Capriello S, et al
    EARLY DETECTION OF BIOCHEMICALLY OCCULT AUTONOMOUS THYROID NODULES.
    Eur J Endocrinol. 2016 Sep 19. pii: EJE-16-0568.
    PubMed     Text format     Abstract available


  88. DONOVAN P, McLeod D, Little R, Gordon L, et al
    Cost-Utility Analysis Comparing Radioactive Iodine, Antithyroid Drugs and Total Thyroidectomy for Primary Treatment of Graves' Disease.
    Eur J Endocrinol. 2016 Sep 15. pii: EJE-16-0527.
    PubMed     Text format     Abstract available


  89. CAMPI I, Vannucchi G, Salvi M
    THERAPY OF ENDOCRINE DISEASE: Endocrine dilemma: management of Graves' orbitopathy.
    Eur J Endocrinol. 2016;175:R117-33.
    PubMed     Text format     Abstract available


    July 2016
  90. ROUCHER-BOULEZ F, Mallet-Motak D, Samara-Boustani D, Jilani H, et al
    NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.
    Eur J Endocrinol. 2016;175:73-84.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: